Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
1 "Glycosphingolipids"
Filter
Filter
Article category
Keywords
Publication year
Authors
Review
Glycosphingolipid Modification: Structural Diversity, Functional and Mechanistic Integration of Diabetes
Tadashi Yamashita
Diabetes Metab J. 2011;35(4):309-316.   Published online August 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.4.309
  • 3,699 View
  • 39 Download
  • 5 Crossref
AbstractAbstract PDFPubReader   

Glycosphingolipids (GSLs) are present in all mammalian cell plasma membranes and intracellular membrane structures. They are especially concentrated in plasma membrane lipid domains that are specialized for cell signaling. Plasma membranes have typical structures called rafts and caveola domain structures, with large amounts of sphingolipids, cholesterol, and sphingomyelin. GSLs are usually observed in many organs ubiquitously. However, GSLs, including over 400 derivatives, participate in diverse cellular functions. Several studies indicate that GSLs might have an effect on signal transduction related to insulin receptors and epidermal growth factor receptors. GSLs may modulate immune responses by transmitting signals from the exterior to the interior of the cell. Guillain-Barré syndrome is one of the autoimmune disorders characterized by symmetrical weakness in the muscles of the legs. The targets of the immune response are thought to be gangliosides, which are one group of GSLs. Other GSLs may serve as second messengers in several signaling pathways that are important to cell survival or programmed cell death. In the search for clear evidence that GSLs may play critical roles in various biological functions, many researchers have made genetically engineered mice. Before the era of gene manipulation, spontaneous animal models or chemical-induced disease models were used.

Citations

Citations to this article as recorded by  
  • Quantitative proteomics reveals Piccolo as a candidate serological correlate of recovery from Guillain-Barré syndrome
    Lourdes Mateos-Hernández, Margarita Villar, Ernesto Doncel-Pérez, Marco Trevisan-Herraz, Ángel García-Forcada, Francisco Romero Ganuza, Jesús Vázquez, José de la Fuente
    Oncotarget.2016; 7(46): 74582.     CrossRef
  • Convergence and divergence of genetic and modular networks between diabetes and breast cancer
    Xiaoxu Zhang, Yingying Zhang, Yanan Yu, Jun Liu, Ye Yuan, Yijun Zhao, Haixia Li, Jie Wang, Zhong Wang
    Journal of Cellular and Molecular Medicine.2015; 19(5): 1094.     CrossRef
  • Profiling over 1500 Lipids in Induced Lung Sputum and the Implications in Studying Lung Diseases
    Ruben t’Kindt, Eef D. Telenga, Lucie Jorge, Antoon J. M. Van Oosterhout, Pat Sandra, Nick H. T. Ten Hacken, Koen Sandra
    Analytical Chemistry.2015; 87(9): 4957.     CrossRef
  • Untargeted Lipidomic Analysis in Chronic Obstructive Pulmonary Disease. Uncovering Sphingolipids
    Eef D. Telenga, Roland F. Hoffmann, Ruben t’Kindt, Susan J. M. Hoonhorst, Brigitte W. M. Willemse, Antoon J. M. van Oosterhout, Irene H. Heijink, Maarten van den Berge, Lucie Jorge, Pat Sandra, Dirkje S. Postma, Koen Sandra, Nick H. T. ten Hacken
    American Journal of Respiratory and Critical Care Medicine.2014; 190(2): 155.     CrossRef
  • Immunological cell type characterization and Th1–Th17 cytokine production in a mouse model of Gaucher disease
    Manoj Kumar Pandey, Reena Rani, Wujuan Zhang, Kenneth Setchell, Gregory A. Grabowski
    Molecular Genetics and Metabolism.2012; 106(3): 310.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP